Neovasc

Neovasc, Inc. engages in the development, manufacture and marketing of medical devices. It focuses on Neovast Tiara and Neovasc Reducer products. The company was founded on November 2, 2000 and is headquartered in Richmond, Canada.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Neovasc Inc. is a specialty medical device company that develops and manufactures products for the rapidly growing cardiovascular device marketplace.Neovasc Inc. offers pericardial tissue processing, vascular product development, design, and manufacturing solutions to industry partners.

REDUCER I Study Shows Improvement in Chest Pain Symptoms

Neovasc Announces Publication of Peer-Reviewed Article in EuroIntervention

New York, New York--(Newsfile Corp. - December 15, 2020) -  Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Neovasc Inc. (NASDAQ: NVCN) between October 10, 2018 and October 27, 2020, inclusive (the "Class Period") of the important January 5, 2021 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Neovasc investors under the federal securities laws.To join the Neovasc class action, go...

ROSEN, RESPECTED INVESTOR COUNSEL, Reminds Neovasc Inc. Investors of Important January 5 Deadline in Securities Class Action - NVCN

VANCOUVER and MINNEAPOLIS, Dec. 15, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) announced today that it has completed the first three Neovasc Reducer™ (“Reducer”) implants in France. The implants are an important step for Neovasc as the Company continues to expand access for Reducer therapy to patients suffering from refractory angina.

Neovasc Announces First Neovasc Reducer™ Implants in France

Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - December 15, 2020) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") announced today that it has completed the first three Neovasc Reducer™ ("Reducer") implants in France. The implants are an important step for Neovasc as the Company continues to expand access for Reducer therapy to patients suffering from refractory angina.The implants were conducted by Prof. Martine Gilard, Director of Interventional Cardiology, and Prof. Romain...

Neovasc Announces First Neovasc Reducer(TM) Implants in France

NEW YORK, Dec. 12, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ: NVCN) and certain of its officers.   The class action, filed in United States District Court for the Southern District of New York, and docketed under 20-cv-09948, is on behalf of a class consisting of all persons other than Defendants who purchased or otherwise acquired Neovasc securities between October 10, 2018 and October 27, 2020, inclusive (the “Class Period”). Plaintiff pursues claims against the Defendants under the Securities Exchange Act of 1934 (the “Exchange Act”).

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Neovasc Inc. of Class Action Lawsuit and Upcoming Deadline – NVCN

Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - December 10, 2020) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") , announced today that it has received written notification (the "Notification Letter") from The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it is not in compliance with the minimum market value requirement set forth in Nasdaq Rules for continued listing on the Nasdaq Capital Market. Nasdaq Listing Rule 5550(b)(2) requires...

Neovasc Receives Nasdaq Notification Regarding Minimum Market Value Deficiency

VANCOUVER and MINNEAPOLIS, Dec. 10, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. ("Neovasc" or the "Company") ( NASDAQ , TSX : NVCN) announced today that it has closed its previously announced registered direct offering (the "Offering") priced at-the-market under the Nasdaq Capital Market (the "Nasdaq") rules of an aggregate of 6,230,803 common shares at a price of US$0.9801 per common share.  Aggregate gross proceeds to the Company were approximately US$6.1 million, before deducting placement agent's fees and estimated expenses of the Offering payable by the Company. 

Neovasc Announces Closing of US$6.1 Million Registered Direct Offering Priced At-the-Market

NEW YORK, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Neovasc Inc. (NASDAQ: NVCN) from November 1, 2019 through October 27, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Neovasc Inc. investors under the federal securities laws.

INVESTOR DEADLINE-NVCN: Pawar Law Group Announces a Securities Class Action Lawsuit Against Neovasc Inc. – NVCN

Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - December 8, 2020) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") announced today that it has entered into definitive agreements with certain healthcare-focused institutional investors for the sale of an aggregate of 6,230,803 common shares at a purchase price of US$0.9801 per common share in a registered direct offering (the "Offering") priced at-the-market under the Nasdaq Capital Market (the "Nasdaq") rules. Aggregate...

Neovasc Announces US$6.1 Million Registered Direct Offering Priced At-the-Market

New York, New York--(Newsfile Corp. - December 6, 2020) -  Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Neovasc Inc. (NASDAQ: NVCN) between November 1, 2019 and October 27, 2020, inclusive (the "Class Period") of the important January 5, 2021 lead plaintiff deadline in the case. The lawsuit seeks to recover damages for Neovasc investors under the federal securities laws.To join the Neovasc class action, go to http://www.rosenlegal.com/cases-register-1976.html...

Rosen, National Trial Lawyers, Reminds Neovasc Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - NVCN

NEW YORK, Dec. 03, 2020 (GLOBE NEWSWIRE) -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Neovasc Inc. (NASDAQ: NVCN) between November 1, 2019 and October 27, 2020, inclusive (the “Class Period”).

Zhang Investor Law Alerts Investors to Deadline in Securities Class Action Lawsuit Against Neovasc Inc. – NVCN

LOS ANGELES--(BUSINESS WIRE)---- $NVCN #NVCN--SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Neovasc Inc.

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Neovasc Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

New York, New York--(Newsfile Corp. - December 1, 2020) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Neovasc Inc. (NASDAQ: NVCN) between November 1, 2019 and October 27, 2020, inclusive (the "Class Period") of the important January 5, 2021 lead plaintiff deadline in the case. The lawsuit seeks to recover damages for Neovasc investors under the federal securities laws.To join the Neovasc class action, go to http://www.rosenlegal.com/cases-register-1976.html...

ROSEN, TRUSTED INVESTOR COUNSEL, Reminds Neovasc Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - NVCN

VANCOUVER and MINNEAPOLIS, Dec. 01, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), today announced their participation in Noble Capital Markets' Virtual Road Show Series, presented by Channelchek, scheduled for December 8, 2020.

Neovasc Announces Participation in Noble Capital Markets Virtual Road Show Series

NEW YORK, Nov. 25, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Neovasc Inc. (NASDAQ: NVCN) between November 1, 2019 and October 27, 2020, inclusive (the "Class Period") of the important January 5, 2021 lead plaintiff...

ROSEN, A LEADING AND LONGSTANDING LAW FIRM, Reminds Neovasc Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - NVCN

NEW YORK, Nov. 25, 2020 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) and certain of its officers. The class action, filed in United States District Court for the Southern District of New...

Pomerantz Law Firm Announces the Filing of a Class Action against Neovasc Inc. and Certain Officers - NVCN

LOS ANGELES, Nov. 23, 2020 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) securities between November 1,...

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Neovasc Inc. (NVCN) Investors

New York, New York--(Newsfile Corp. - November 20, 2020) -  Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Neovasc Inc. (NASDAQ: NVCN) between November 1, 2019 and October 27, 2020, inclusive (the "Class Period") of the important January 5, 2021 lead plaintiff deadline in the case. The lawsuit seeks to recover damages for Neovasc investors under the federal securities laws.To join the Neovasc class action, go to http://www.rosenlegal.com/cases-register-1976.html...

ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Neovasc Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - NVCN

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Neovasc Inc. (NASDAQ: NVCN) between November 1, 2019 and October 27, 2020, inclusive (the “Class Period”) of the important January 5, 2021 lead plaintiff deadline in the case. The lawsuit seeks to recover damages for Neovasc investors under the federal securities laws. To join the Neovasc class action, go to http://www.rosenlegal.com/cases-register-1976.html or call Phillip Kim,

ROSEN, A LEADING AND TOP RANKED LAW FIRM, Reminds Neovasc Inc. Investors of Important Deadline in Securities Class Action – NVCN

NEW YORK--(BUSINESS WIRE)--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Neovasc Inc. ("Neovasc" or "the Company") (NASDAQ: NVCN) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Neovasc securities between November 1, 2019 and October 27, 2020, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/nvcn. This cla

NVCN Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Neovasc Inc. Investors of Class Action and Lead Plaintiff Deadline: January 5, 2021

VANCOUVER, Nov. 16, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc, Inc. (NASDAQ, TSX: NVCN), today announced that company management will be participating in the Canaccord Genuity 2020 Virtual MedTech & Diagnostics Forum on Thursday, November 19, 2020.  Fred Colen, Neovasc's President and Chief Executive Officer, will deliver a presentation at 11:00 am EST.  Mr. Colen will also be joined by Chief Financial Officer Chris Clark, and Chief Operating Officer Bill Little, for investor meetings throughout the day.

Neovasc to Participate in Canaccord Genuity 2020 Virtual MedTech & Diagnostics Forum

New York, New York--(Newsfile Corp. - November 13, 2020) -  Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Neovasc Inc. (NASDAQ: NVCN) between November 1, 2019 and October 27, 2020, inclusive (the "Class Period") of the important January 5, 2021 lead plaintiff deadline in the case. The lawsuit seeks to recover damages for Neovasc investors under the federal securities laws.To join the Neovasc class action, go to http://www.rosenlegal.com/cases-register-1976.html...

ROSEN, A LEADING LAW FIRM, Reminds Neovasc Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $500K to Contact the Firm - NVCN

New York, New York--(Newsfile Corp. - November 13, 2020) - The Brualdi Law Firm, P.C. announces that a lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Neovasc, Inc. ("Neovasc") (NASDAQ: NVCN) stock during the period between November 1, 2019 and October 27, 2020, inclusive (the "Class Period"), for violations of the federal securities laws.No class has yet been certified in that...

The Brualdi Law Firm, P.C. Announces Class Action Lawsuit against Neovasc, Inc.

NEW YORK, Nov. 11, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Neovasc Inc. between November 1, 2019 and October 27, 2020, inclusive (the "Class Period") of the important January 5, 2021 lead plaintiff deadline in the...

ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Reminds Neovasc Inc. Investors of Important Deadline in Securities Class Action - NVCN

NEW YORK, Nov. 10, 2020 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The...

News for Neovasc Stock (NVCN)